Activist investor Keith Meister will join the board of gene-sequencing maker Illumina , and current board member Scott ...

In this article, we are going to take a look at where Illumina, Inc. (NASDAQ:ILMN) stands against the other best diagnostics stocks to invest in right now. Overview of the Clinical Diagnostics ...

Illumina, Inc. ILMN and Nashville Biosciences, LLC (NashBio) recently announced that 250,000 whole genomes have been sequenced for the Alliance for Genomic Discovery (AGD) initiative. The insights ...

Keith Meister’s hedge fund Corvex Management has a 2.5% stake in the gene-sequencing machine maker.

The authors have generated important resources such as a reference dataset of early primate development by utilizing single-cell transcriptomic technology together with induced pluripotent stem cells ...

In a case that had been closely watched across multiple industries, Illumina chose to divest Grail in the light of legal action from the European Commission and the US Federal Trade Commission.

It employs recombinant DNA, DNA sequencing methods, and bioinformatics to sequence, assemble, and analyse the structure and function of genomes. Based on genome-wide association study data from 2. ...

After hours: March 21 at 7:59:43 PM EDT Loading Chart for ILMN ...

After hours: 21 March at 7:59:43 pm GMT-4 Loading Chart for ILMN ...

1μg of total cellular RNA was used for sequencing library generation by NEBNext Ultra RNA Library Prep Kit for Illumina (NEB, USA, Catalog #: E7530L) following manufacturer’s recommendations and index ...